Description
Conicil 10/20 mg is combination of Cilnidipine, a fourth-generation calcium channel blocker, exhibits a dual L/N-type Ca2+ channel-blocking action. It suppresses the neurohumoral control of the CV system, including the sympathetic nervous system and the renin angiotensin-aldosterone system (RAAS) through N-type Ca2+ channel blockade, and is beneficial in different complications of hypertension. It also exhibits Reno protective effects. Cilnidipine is used in the management of hypertension either as a monotherapy or as a combination therapy with ARB.
Each tablet contains Cilnidipine 10/20 mg
Cilnidipine, the novel CCB, is preferred in hypertension management. It is well tolerated and has consistent, effective, and smooth control of 24-hour BP and reduces proteinuria by decreasing intraglomerular pressure in both afferent and efferent arterioles of glomeruli.
It controls heart rate and proteinuria. Reno-protective, neuroprotective, and cardio protective effects of cilnidipine have been well-documented and demonstrated.
Ones daily or recommended by the Physician.
Store below 30°C
- Composition
-
Each tablet contains Cilnidipine 10/20 mg
- Indication
-
Cilnidipine, the novel CCB, is preferred in hypertension management. It is well tolerated and has consistent, effective, and smooth control of 24-hour BP and reduces proteinuria by decreasing intraglomerular pressure in both afferent and efferent arterioles of glomeruli.
- Benefits
-
It controls heart rate and proteinuria. Reno-protective, neuroprotective, and cardio protective effects of cilnidipine have been well-documented and demonstrated.
- Doses
-
Ones daily or recommended by the Physician.
- Storage
-
Store below 30°C